121 related articles for article (PubMed ID: 31180621)
1. Increased miR-323a induces bladder cancer cell apoptosis by suppressing c-Met.
Qiu J; Zeng FR; Fang Y; Li J; Xiao SY
Kaohsiung J Med Sci; 2019 Sep; 35(9):542-549. PubMed ID: 31180621
[TBL] [Abstract][Full Text] [Related]
2. MET/SMAD3/SNAIL circuit mediated by miR-323a-3p is involved in regulating epithelial-mesenchymal transition progression in bladder cancer.
Li J; Xu X; Meng S; Liang Z; Wang X; Xu M; Wang S; Li S; Zhu Y; Xie B; Lin Y; Zheng X; Liu B; Xie L
Cell Death Dis; 2017 Aug; 8(8):e3010. PubMed ID: 28837140
[TBL] [Abstract][Full Text] [Related]
3. Oncogene miR-187-5p is associated with cellular proliferation, migration, invasion, apoptosis and an increased risk of recurrence in bladder cancer.
Li Z; Lin C; Zhao L; Zhou L; Pan X; Quan J; Peng X; Li W; Li H; Xu J; Xu W; Guan X; Chen Y; Lai Y
Biomed Pharmacother; 2018 Sep; 105():461-469. PubMed ID: 29883941
[TBL] [Abstract][Full Text] [Related]
4. Tumor-suppressor microRNA-139-5p restrains bladder cancer cell line ECV-304 properties via targeting Connexin 43.
Chi Q; Wang ZY; Li HY; Song DB; Xu H; Ma G; Wang ZM; Li XM
Chin Med J (Engl); 2019 Oct; 132(19):2354-2361. PubMed ID: 31567382
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA NORAD inhibition upregulates microRNA-323a-3p to suppress tumorigenesis and development of breast cancer through the PUM1/eIF2 axis.
Shi P; Zhang J; Li X; Li W; Li H; Fu P
Cell Cycle; 2021 Jul; 20(13):1295-1307. PubMed ID: 34125645
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-101 suppresses motility of bladder cancer cells by targeting c-Met.
Hu Z; Lin Y; Chen H; Mao Y; Wu J; Zhu Y; Xu X; Xu X; Li S; Zheng X; Xie L
Biochem Biophys Res Commun; 2013 May; 435(1):82-7. PubMed ID: 23618864
[TBL] [Abstract][Full Text] [Related]
7. MiR-15 suppressed the progression of bladder cancer by targeting BMI1 oncogene via PI3K/AKT signaling pathway.
Zhang L; Wang CZ; Ma M; Shao GF
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8813-8822. PubMed ID: 31696468
[TBL] [Abstract][Full Text] [Related]
8. MiR-124-3p suppresses bladder cancer by targeting DNA methyltransferase 3B.
Zo RB; Long Z
J Cell Physiol; 2018 Jan; 234(1):464-474. PubMed ID: 29893409
[TBL] [Abstract][Full Text] [Related]
9. Reduction of miR-212 contributes to pituitary adenoma cell invasion via targeting c-Met.
Wang HY; Gao HQ
Kaohsiung J Med Sci; 2020 Feb; 36(2):81-88. PubMed ID: 31643121
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-409-3p inhibits migration and invasion of bladder cancer cells via targeting c-Met.
Xu X; Chen H; Lin Y; Hu Z; Mao Y; Wu J; Xu X; Zhu Y; Li S; Zheng X; Xie L
Mol Cells; 2013 Jul; 36(1):62-8. PubMed ID: 23820886
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-124-3p affects proliferation, migration and apoptosis of bladder cancer cells through targeting AURKA.
Yuan Q; Sun T; Ye F; Kong W; Jin H
Cancer Biomark; 2017; 19(1):93-101. PubMed ID: 28269755
[TBL] [Abstract][Full Text] [Related]
12. YWHAE long non-coding RNA competes with miR-323a-3p and miR-532-5p through activating K-Ras/Erk1/2 and PI3K/Akt signaling pathways in HCT116 cells.
Bjeije H; Soltani BM; Behmanesh M; Zali MR
Hum Mol Genet; 2019 Oct; 28(19):3219-3231. PubMed ID: 31238337
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-294 Promotes Cellular Proliferation and Motility through the PI3K/AKT and JAK/STAT Pathways by Upregulation of NRAS in Bladder Cancer.
Li Y; Shan Z; Liu C; Yang D; Wu J; Men C; Xu Y
Biochemistry (Mosc); 2017 Apr; 82(4):474-482. PubMed ID: 28371605
[TBL] [Abstract][Full Text] [Related]
14. MiR-212-3p inhibits cell proliferation and promotes apoptosis by targeting nuclear factor IA in bladder cancer.
Wu X; Chen H; Zhang G; Wu J; Zhu W; Gu Y; He YI
J Biosci; 2019 Sep; 44(4):. PubMed ID: 31502558
[TBL] [Abstract][Full Text] [Related]
15. miR-383-5p serves as a tumor suppressor in bladder cancer by suppressing PI3K/AKT signaling pathway.
Liu Y; Yu H; Zeng B; Gou X; Ren K; Yuan F
Cancer Biomark; 2023; 37(2):121-131. PubMed ID: 37248889
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-1826 targets VEGFC, beta-catenin (CTNNB1) and MEK1 (MAP2K1) in human bladder cancer.
Hirata H; Hinoda Y; Ueno K; Shahryari V; Tabatabai ZL; Dahiya R
Carcinogenesis; 2012 Jan; 33(1):41-8. PubMed ID: 22049531
[TBL] [Abstract][Full Text] [Related]
17. miR-451 suppresses bladder cancer cell migration and invasion via directly targeting c-Myc.
Wang J; Zhao X; Shi J; Pan Y; Chen Q; Leng P; Wang Y
Oncol Rep; 2016 Oct; 36(4):2049-58. PubMed ID: 27571748
[TBL] [Abstract][Full Text] [Related]
18. Dual regulation of receptor tyrosine kinase genes EGFR and c-Met by the tumor-suppressive microRNA-23b/27b cluster in bladder cancer.
Chiyomaru T; Seki N; Inoguchi S; Ishihara T; Mataki H; Matsushita R; Goto Y; Nishikawa R; Tatarano S; Itesako T; Nakagawa M; Enokida H
Int J Oncol; 2015 Feb; 46(2):487-96. PubMed ID: 25405368
[TBL] [Abstract][Full Text] [Related]
19. The long noncoding RNA ZFAS1 facilitates bladder cancer tumorigenesis by sponging miR-329.
Wang JS; Liu QH; Cheng XH; Zhang WY; Jin YC
Biomed Pharmacother; 2018 Jul; 103():174-181. PubMed ID: 29653362
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-203 Is a Prognostic Indicator in Bladder Cancer and Enhances Chemosensitivity to Cisplatin via Apoptosis by Targeting Bcl-w and Survivin.
Zhang X; Zhang Y; Liu X; Fang A; Li P; Li Z; Liu T; Yang Y; Du L; Wang C
PLoS One; 2015; 10(11):e0143441. PubMed ID: 26599571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
